Presentation
Jyothy Laboratories Ltd has submitted to BSE a copy of Presentation.16-02-2016
Intimation of Schedule of Analyst/ Institutional Investor Meet
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Schedule of Analyst/ Institutional Investor Meet".Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
M P Ramachandran has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSESpurred by Patanjali's success, Jyothy Labs builds on herbal' equity
To extend portfolio of heritage brands Neem, MargoShareholding for the Period Ended December 31, 2015
Jyothy Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click hereJyothy Labs Q3 net profit rises 47.4% to Rs38.99 crore
Net profit rose to Rs38.99 crore in the three month ended 31 December from Rs26.46 crore a year earlierResults Press Release
Jyothy Laboratories Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2015.Financial Results & Limited Review Report for Dec 31, 2015
Jyothy Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report (Standalone & Consolidated) for the period ended December 31, 2015.Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Jyothy Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Intimation of Investor/ Analyst Call submitted on January 08, 2016
Jyothy Laboratories Ltd has informed BSE regarding "Intimation of Investor/ Analyst Call submitted on January 08, 2016".